Cargando…

Upregulated Histone Deacetylase 6 Associates with Malignant Progression of Melanoma and Predicts the Prognosis of Patients

BACKGROUND: Melanoma is the most malignant tumor among skin tumors, and its morbidity and mortality are increasing year by year. Although melanoma biology has been increasingly studied, no prognostic biomarkers have yet been incorporated into clinical protocols. Histone deacetylase 6 (HDAC6) has bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Zhicheng, Rong, Yanchao, Li, Shuting, Qu, Shanqiang, Huang, Shaobin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751721/ https://www.ncbi.nlm.nih.gov/pubmed/33364845 http://dx.doi.org/10.2147/CMAR.S284199

Ejemplares similares

Upregulation of Piezo1 Is a Novel Prognostic Indicator in Glioma Patients
por: Qu, Shanqiang, et al.
Publicado: (2020)

The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancy
por: Cao, Lin-Lin, et al.
Publicado: (2017)

Stenotrophomonas maltophilia promotes lung adenocarcinoma progression by upregulating histone deacetylase 5
por: Shen, Jiyu, et al.
Publicado: (2023)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

SIRT6 histone deacetylase functions as a potential oncogene in human melanoma
por: Garcia-Peterson, Liz Mariely, et al.
Publicado: (2017)

Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
por: Mao, Chaofu, et al.
Publicado: (2022)

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies
por: Bishton, Mark J., et al.
Publicado: (2010)

Histone Deacetylases (HDACs) Guided Novel Therapies for T-cell lymphomas
por: Zhang, Qing, et al.
Publicado: (2019)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Evaluation of the Therapeutic Potential of Histone Deacetylase 6 Inhibitors for Primary and Metastatic Uveal Melanoma
por: Sundaramurthi, Husvinee, et al.
Publicado: (2022)

EVA1C Is a Potential Prognostic Biomarker and Correlated With Immune Infiltration Levels in WHO Grade II/III Glioma
por: Hu, Zhicheng, et al.
Publicado: (2021)

Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy
por: Haery, Leila, et al.
Publicado: (2015)

Histone deacetylase inhibitors: clinical implications for hematological malignancies
por: Tambaro, Francesco Paolo, et al.
Publicado: (2010)

Histone Deacetylase 6 as a Therapeutic Target in B cell-associated Hematological Malignancies
por: Yang, Jia, et al.
Publicado: (2020)

Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
por: Wang, Jiayu, et al.
Publicado: (2022)

Association of histone deacetylase expression with histology and prognosis of ovarian cancer
por: Yano, Mitsutake, et al.
Publicado: (2018)

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors
por: Federico, Mario, et al.
Publicado: (2011)

Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies
por: Imai, Yoichi, et al.
Publicado: (2016)

Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
por: Ungerstedt, Johanna S.
Publicado: (2018)

Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
por: Li, Yan, et al.
Publicado: (2022)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Prognosis Analysis of Histone Deacetylases mRNA Expression in Ovarian Cancer Patients
por: Zhou, Lulu, et al.
Publicado: (2018)

Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer: A meta-analysis
por: Cao, Lin-Lin, et al.
Publicado: (2017)

Targeted inhibition of histone deacetylase 6 in inflammatory diseases
por: Ran, Jie, et al.
Publicado: (2019)

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
por: Lemos, Miguel, et al.
Publicado: (2020)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

N6‐methyladenine‐related genes affect biological behavior and the prognosis of glioma
por: Qu, Shanqiang, et al.
Publicado: (2020)

Histone Deacetylase (HDAC)-1, -2, -4, and -6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients’ Survival
por: Levidou, Georgia, et al.
Publicado: (2021)

β-Hydroxybutyrate upregulates FGF21 expression through inhibition of histone deacetylases in hepatocytes
por: Yan, Aili, et al.
Publicado: (2022)

Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies
por: Ellis, Leigh, et al.
Publicado: (2010)

Epigenetic Alterations Induced by Photothrombotic Stroke in the Rat Cerebral Cortex: Deacetylation of Histone h3, Upregulation of Histone Deacetylases and Histone Acetyltransferases
por: Demyanenko, Svetlana, et al.
Publicado: (2019)

Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma
por: Yeon, Minjeong, et al.
Publicado: (2020)

Histone deacetylase inhibitors: a promising partner for MEK inhibitors in uveal melanoma?
por: Faião-Flores, Fernanda, et al.
Publicado: (2019)

Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma
por: Liu, Jinfang, et al.
Publicado: (2021)

Histone deacetylase 6’s function in viral infection, innate immunity, and disease: latest advances
por: Qu, Min, et al.
Publicado: (2023)

Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
por: Hai, Yang, et al.
Publicado: (2016)

Histone deacetylase 6 modulates macrophage infiltration during inflammation
por: Yan, Bing, et al.
Publicado: (2018)

Expression and cilia associated localization of Histone deacetylases 6 in Xenopus
por: Tisler, Matthias, et al.
Publicado: (2023)

Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
por: Beljkas, Milan, et al.
Publicado: (2023)

Comprehensive analysis of histone deacetylases genes in the prognosis and immune infiltration of glioma patients
por: Shen, Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ei68afintfnaro5sn828bfc580